PTX3 and systemic lupus erythematosus: Moreover, in a previous work, we demonstrated that anti-PTX3 aAbs prevalence was low in rheumatoid arthritis patients, while detected in 50% of patients with SLE, a disease also associated with excessive NETosis [17, 40].